Caroline Wagner is a professor of public affairs at The Ohio State University. She receives funding from SECURE, a research security service funded by the National Science Foundat ...

The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

The FDA has revoked the authorization for the use of FD&C Red No. 3 in food and ingested drugs due to evidence suggesting this dye can cause cancer in rats.

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.

Our findings highlight divergent trends, such as the global reduction in tobacco-associated mortality but rising mortality linked to ambient particulate matter,” researchers wrote.

The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.

Clear toxicity data reporting and interpretation are necessary for clinicians and patients to draw clinically meaningful conclusions from clinical trials,” according to researchers.

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Data suggest that states with strict abortion bans are losing residents, particularly younger people, which could have long-term economic implications.

Scheduling radiotherapy in the morning may be beneficial for patients with nasopharyngeal carcinoma, but additional study is needed to confirm this finding, according to researchers.